As of May 28, 2025, Fine Foods & Pharmaceuticals NTM SpA (FF.MI) reports a Gross Margin of 32.69%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Fine Foods & Pharmaceuticals NTM SpA's Gross Margin
Over recent years, Fine Foods & Pharmaceuticals NTM SpA's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 32.69% |
| 2023-12-31 | 27.32% |
| 2022-12-31 | 26.35% |
| 2021-12-31 | 28.79% |
| 2020-12-31 | 28.25% |
This fluctuation highlights how Fine Foods & Pharmaceuticals NTM SpA manages its operational efficiency and pricing power over time.
Comparing Fine Foods & Pharmaceuticals NTM SpA's Gross Margin to Peers
To better understand Fine Foods & Pharmaceuticals NTM SpA's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Fine Foods & Pharmaceuticals NTM SpA (FF.MI) | 32.69% |
| C4X Discovery Holdings PLC (C4XD.L) | 97.78% |
| Eurofins-Cerep SA (ALECR.PA) | 86.74% |
| Diaceutics PLC (DXRX.L) | 83.15% |
| Chemometec A/S (CHEMM.CO) | 78.80% |
| Selvita SA (SLV.WA) | 78.54% |
Compared to its competitors, Fine Foods & Pharmaceuticals NTM SpA's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.